[Edaily Starin Choi Hee-jae Reporter] “What’s going on? What’s all this commotion?” Why did Heo Kyung-hwan and Joo Woo-jae shed tears? (Photo = MBC) MBC’s “What’s Going On! What’s All This Commotion?” (“What’s Going On”), which premieres on the 9th of next month, is a spin-off of “What Do You Do When You’re Bored?” It has drawn attention with previews showing Haha, Heo Kyung-hwan, and Joo Woo-jae embarking on a trip to fill the broadcast gap left by Yoo Jae-suk’s absence. Two teaser videos released on the 26th sparked curiosity by showing the three men laughing, crying, and causing quite a commotion at their travel destination. Heo Kyung-hwan, who had previously suffered from separation anxiety when Yoo Jae-suk was absent, showed he could have fun better than anyone else by belting out the catchphrase “I’m doing it right now” with great enthusiasm at a karaoke bar. The sight of the three men, whose chemistry was impeccable when it came to having fun, captivated viewers. (Photo = MBC) Meanwhile, the teasers also captured Joo Woo-jae and Heo Kyung-hwan in tears. Since this is a side of them rarely seen on *What Do You Do When You Play?*, it has drawn intense interest in their travelogue, which promises to showcase their serious and honest sides. “What’s Up, What’s Up?” is a travelogue about three men whose even their time off doesn’t go as planned, and it will air on the 9th, 16th, and 23rd of next month at 9:40 p.m. Haha, Ju Woo-jae, and Heo Kyung-hwan are regular cast members of “What Do You Do When You’re Bored?” and appear every Saturday. While “What Do You Do When You’re Bored?” will be on hiatus for three weeks due to coverage of the 2026 Aichi-Nagoya Asian Games, “What’s Up, What’s Up?” is scheduled to air on Fridays for those three weeks.
SAMSUNG BIOLOGICS(207940)has announced plans to respond strictly, in accordance with the law and established principles, to any illegal or unlawful acts related to the conflict with the labor union ov…
“‘Jjarur,’ a jajangmyeon-flavored instant noodle made with lard, sold 10 million servings within 100 days of its launch. The company aims to surpass 10 billion won in sales by the end of the year.” (K…
NeoImmuneTech, Inc.(950220)announced on the 7th that its U.S. partner, Tolerance Bio, presented “NT-I7” (epineptakin alfa), a long-acting interleukin-7 (IL-7) candidate, as a key clinical pipeline for…